American Vietnamese Biotech

American Vietnamese Biotech EBIT Margin

The EBIT Margin (Operating Margin) of American Vietnamese Biotech (AMV.VN) as of Oct 17, 2026 is -1.39 %. In the previous year, EBIT Margin (Operating Margin) was 16.34 % — a change of -108.50% (lower).

EBIT Margin

-1.39 %

YoY

-108.50%

Last updated:

EBIT Margin (Operating Margin) of American Vietnamese Biotech is 2024 -1.39 % . EBIT Margin (Operating Margin) of American Vietnamese Biotech was 2023 16.34 % . It decreases by -108.50% lower compared to the previous year.

For American Vietnamese Biotech, the operating (EBIT) margin of -1.4% is down versus 42.9% a few years ago.

The American Vietnamese Biotech EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2017
55.62 VND
Jan 1, 2018
49.29 VND
Jan 1, 2019
46.57 VND
Jan 1, 2020
42.89 VND
Jan 1, 2021
43.49 VND
Jan 1, 2022
22.99 VND
Jan 1, 2023
16.34 VND
Jan 1, 2024
-1.39 VND
The American Vietnamese Biotech EBIT Margin history
YEAREBIT MarginYoY
-1.39 %-108.50%
16.34 %-28.90%
22.99 %-47.14%
43.49 %+1.40%
42.89 %-7.90%
46.57 %-5.51%
49.29 %-11.38%
55.62 %+257.44%
15.56 %+118.87%
7.11 %-109.54%
-74.50 %-131,765.27%
0.06 %+6.74%
0.05 %-140.44%
-0.13 %-170.50%
0.19 %+65.16%
0.11 %-41.34%
0.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

American Vietnamese Biotech Stock analysis

What does American Vietnamese Biotech do? American Vietnamese Biotech Inc, headquartered in Ho Chi Minh City, Vietnam, operates in the Health Care sector. The company manufactures and distributes high-tech medical diagnostics devices, equipment, medicines, vaccines, biological products, rapid diagnostic tests, and ELISA kits. It also trades medical equipment and tools, produces cosmetic, soap, detergent, and cleaning products, and engages in real estate trading, financial investments, and plastic product manufacturing. Listed on December 20, 2009, the company had one wholly owned subsidiary as of 2012. American Vietnamese Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about American Vietnamese Biotech stock

EBIT Margin (Operating Margin) of American Vietnamese Biotech is -1.39 % in 2024.

EBIT Margin (Operating Margin) of American Vietnamese Biotech changed from 16.34 % to -1.39 %, representing a -108.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) American Vietnamese Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s American Vietnamese Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — American Vietnamese Biotech

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — American Vietnamese Biotech